Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malignant peritoneal mesothelioma.

Kamal E Bani-Hani1, Kamal A Gharaibeh

  • 1Department of Surgery, King Abdullah University Hospital, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan. banihani60@yahoo.com

Journal of Surgical Oncology
|July 7, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fast Foods, Sweets and Beverage Consumption and Risk of Colorectal Cancer: A Case-Control Study in Jordan

Asian Pacific journal of cancer prevention : APJCP·2018
Same author

Cystic echinococcosis in Jordan: A review of causative species, previous studies, serological and radiological diagnosis.

Acta tropica·2017
Same author

Dietary inflammatory index and odds of colorectal cancer in a case-control study from Jordan.

Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme·2017
Same author

Dietary patterns and colorectal cancer.

Clinical nutrition (Edinburgh, Scotland)·2016
Same author

Consumption of Whole Grains, Refined Cereals, and Legumes and Its Association With Colorectal Cancer Among Jordanians.

Integrative cancer therapies·2015
Same author

Macro- and micronutrients consumption and the risk for colorectal cancer among Jordanians.

Nutrients·2015
Same journal

Institutional Learning Curve in Esophagectomy: Technical Standardization of Gastric Conduit Formation and Conduit-Related Outcomes in 187 Consecutive Patients.

Journal of surgical oncology·2026
Same journal

Evaluating the Accuracy of ChatGPT-4o in Addressing Complex Clinical Questions Based on NCCN Guidelines for Rectal Adenocarcinoma.

Journal of surgical oncology·2026
Same journal

Racial Differences in Breast Cancer Treatment and Information Access.

Journal of surgical oncology·2026
Same journal

Comparative Analysis of CEM and Breast MRI: A Retrospective Study.

Journal of surgical oncology·2026
Same journal

The Treatment Efficacy for Patients Undergoing Combined Transanal-Transabdominal Endoscopic Resection of Rectal Anastomosis Stenosis.

Journal of surgical oncology·2026
Same journal

"It Depends on the Situation": Variability in How Surgical Oncologists Elicit and Integrate Patient Values.

Journal of surgical oncology·2026
See all related articles

Malignant peritoneal mesothelioma (MPM) is often misdiagnosed, highlighting the need for increased awareness. Cytoreductive surgery with hyperthermic intraoperative intraperitoneal chemotherapy (HIIC) shows promise for improving outcomes in select MPM patients.

Area of Science:

  • Oncology
  • Surgical Pathology

Background:

  • Malignant peritoneal mesothelioma (MPM) incidence is increasing.
  • Early misdiagnosis is common, necessitating greater disease awareness.

Purpose of the Study:

  • To present clinical experience with MPM to improve diagnostic accuracy.
  • To highlight key diagnostic and therapeutic challenges.

Main Methods:

  • Retrospective review of seven histologically confirmed MPM cases.
  • Detailed analysis of demographic and clinicopathological data.
  • Immunohistochemistry for calretinin expression.

Main Results:

  • No preoperative diagnoses were made; average diagnostic delay was 10 months.
  • Calretinin expression confirmed MPM in all cases.

Related Experiment Videos

  • Two survivors received cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy (HIIC); median survival was 19.7 months.

    • Conclusions:

    • Increased awareness and prompt diagnosis are crucial for managing MPM.
    • Immunohistochemistry is vital for accurate MPM diagnosis.
    • Cytoreductive surgery is the mainstay of treatment, with HIIC offering a promising therapeutic strategy.